Evidence map›Paper›PMID 40241761›Full record

ArticleiScience2025

CXCR4

Guilherme Cesar Martelossi Cebinelli, Maísa de Oliveira Leandro, Antonio Edson Rocha Oliveira, Kalil Alves de Lima, Paula Barbim Donate, Cleyson da Cruz Oliveira Barros, Anderson Dos Santos Ramos, Victor Costa, Daniele Carvalho Bernardo Nascimento, Luis Eduardo Alves Damasceno and 6 more

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Guilherme Cesar Martelossi CebinelliCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Maísa de Oliveira LeandroCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Antonio Edson Rocha OliveiraNúcleo de Biologia Experimental, Universidade de Fortaleza (UNIFOR), Fortaleza, CE, Brazil.
Kalil Alves de LimaCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Paula Barbim DonateCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Cleyson da Cruz Oliveira BarrosCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Anderson Dos Santos RamosCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Victor CostaCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Daniele Carvalho Bernardo NascimentoCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Luis Eduardo Alves DamascenoCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Amanda Curto TavaresCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
André Nicolau Aquime GonçalvesCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Helder Takashi Imoto NakayaCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Thiago Mattar CunhaCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
José Carlos Alves-FilhoCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Fernando Queiroz CunhaCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School - University of Sao Paulo (USP), Sao Paulo, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dysregulated host response to infections can lead to sepsis, a complex disease characterized by a spectrum of clinical phenotypes. Using scRNA-seq, we analyzed the immune cell of survived and non-survived CLP-septic mice to gain insights into the immunological mechanisms by which neutrophils contribute to the hyperinflammatory phenotype. Our findings reveal that non-survived mice exhibit increased frequencies of immature CXCR4

Indexed as

Biological sciencesImmune responseImmunologyNatural sciences

Identifiers

PMID40241761
PMCPMC12003019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.